Abstract:Chronic bacterial infections are responsible for significant mortality and morbidity in cystic fibrosis (CF) patients. Pseudomonas aeruginosa (Pa), the dominant CF pathogen, and Mycobacterium abscessus (Mab) both cause persistent pulmonary infections that are difficult to treat. Co-infection by both bacterial pathogens leads to severe disease and poor clinical outcomes. To explore understudied interactions between these two CF pathogens, we employed culture- and molecular- based approaches. In a planktonic co-culture model, growth of Pa continued unimpeded, and it exerted a bacteriostatic effect on Mab. Strikingly, exposure of Mab grown in monoculture to cell-free spent supernatant of Pa resulted in a dramatic, dose-dependent bactericidal effect. Initial characterization indicated that this potent Pa-derived anti-Mab cidal activity was mediated by a heat-sensitive, protease-insensitive soluble factor of >3kDa size. Further analysis demonstrated that expression of this mycobactericidal factor requires LasR, a central regulator of Pa quorum sensing (QS). In contrast, DeltaLasR Pa was still able to exert a bacteriostatic effect on Mab during co-culture, pointing to additional LasR-independent factors able to antagonize Mab growth. However, the ability of Mab to adapt during co-culture to counter the cidal effects of a LasR regulated factor suggested complex interspecies dynamics. Dual RNAseq analysis of Mab-Pa co-cultures revealed significant transcriptional remodeling of Mab, with differential expression of 68% of Mab genes compared to minimal transcriptional changes in Pa. Transcriptome analysis reflected slowed Mab growth and remodeling of carbon and energy metabolism akin to a non-replicating persister-like phase. A tailored Mab response to Pa was evident by enhanced transcript levels of genes predicted to interfere with alkylquinolone QS signals or provide protection against respiratory toxins and hydrogen cyanide. This is the first study to provide a transcriptome-level view of genetic responses governing the interplay between two important CF pathogens. This will provide insights into interspecies interaction mechanisms which can be targeted to disrupt their communities in a CF lung to improve patient clinical performance. Moreover, identification of a novel antimicrobial natural product with potent cidal activity against Mab will provide a chemical biology tool for identifying new drug targets in Mab.

Mycobacterium abscessus promotes Pseudomonas aeruginosa biofilm formation and antibiotic tolerance

Mycobacterium abscessus persistence in the face of Pseudomonas aeruginosa antagonism

Interplay of Mycobacterium abscessus and Pseudomonas aeruginosa in coinfection: Biofilm Dynamics and Host Immune Response

Mycobacteroides abscessus ability to interact with the host mucosal cells plays an important role in pathogenesis of the infection

Impact of Mycobacteroides abscessus colony morphology on biofilm formation and antimicrobial resistance

Synergistic Activity of Berberine with Azithromycin Against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung in Vitro and in Vivo.

Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis

Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm

Activity of Antibiotics and Potential Antibiofilm Agents against Biofilm-Producing Mycobacterium avium-intracellulare Complex Causing Chronic Pulmonary Infections

Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm

Altered serine metabolism promotes drug tolerance in Mycobacterium abscessus via a WhiB7-mediated adaptive stress response

Phenylacetic acid metabolic genes are associated with Mycobacteroides abscessus dominant circulating clone 1

Impact of N-Acetylcysteine and Antibiotics Against Single and Dual Species Biofilms of Pseudomonas aeruginosa and Achromobacter xylosoxidans

Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis

Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection

Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis

Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms

Antibiofilm activity of Prevotella species from the cystic fibrosis lung microbiota against Pseudomonas aeruginosa

Psl-Dependent Cooperation Contributes to Drug Resistance of Pseudomonas aeruginosa in Dual-Species Biofilms with Acinetobacter baumannii

Organic Acids and Their Salts Potentiate the Activity of Selected Antibiotics against Pseudomonas aeruginosa Biofilms Grown in a Synthetic Cystic Fibrosis Sputum Medium

Effect of N-Acetylcysteine in Combination with Antibiotics on the Biofilms of Three Cystic Fibrosis Pathogens of Emerging Importance